Medipharm Labs Corp T.LABS

Management failed again when in late 2023 they

[piduks]

publicly stated they were targeting their Q1 2024 quarter to become profitable.   This was stated by them in late 2023, late enough to have good visibility for Q1 2024 performance.   Then to state the stock price was undervalued before becoming profitable was an insult.   I voted my 3.2 million shares by hard copy mail in as "NO" to all excpet for auditors.

[mdjbrown]

Fair enough piduks. If you have 3.2 million shares after the acquisition conversion of 0.29 for every VIVO share you held, then clearly you have much more skin in the game than I do. Wish all Labs shareholders luck with sending a message to the executive board, but in my experience it rarely lights a fire under their backsides. 7 years ago I was heavily invested in a company where 50% of the